KULA, MAUI, HAWAII, Date June 5, 2006 /PRNewswire-FirstCall/ -
Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that Shares of Bioponic Phytoceuticals, Inc.’s common stock will be traded on the Nasdaq Pink Sheets Market under the trading symbol "BPYT".
Bioponic Phytoceuticals is a leading provider of innovative natural products for sale in the Complementary Alternative Medicine (“CAM”) and natural products markets. The Company’s primary products employ a new, patent pending healing modality “Bioresonant Phytotherapeutics™”, and it has introduced the national recognized product “Flight Spray” into national distribution (Magellan’s travel catalog, Drugstore.com, TravelSmith.com and others).
"I am delighted that the Company has taken this important step. We anticipate that the creation of a market for the Company’s stock will advance its strategy to aggressively pursue its sales goals for 2006," said Steven M. Schorr, Chairman & CEO - Bioponic Phytoceuticals, Inc.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful.
Bioponic Phytoceuticals is engaged in the development, formulation, production and distribution of Bioresonant Phytotherapeutic™ products for sale in the Complementary Alternative Medicine (“CAM”) and natural products markets. The Company has developed a new healing modality “Bioresonant Phytotherapeutics™” and several branded product lines currently in distribution (including the nationally recognized natural nasal spray: Flight Spray™). Bioponic is presently focused on the production of natural products that are used by consumers to promote health and well-being, and to prevent disease. www.bioponic.com
Steven M Schorr